PRESCRIPTION DRUG AFFORDABILITY BOARD

REPORTS (MANDATED)

Annual Report to Senate Finance Committee & House Health & Government Operations Committee due Dec. 31, beginning 2021 (Chapter 692, Acts of 2019; Code Health-General Article, secs. 21-2C-01 through 21-2C-15).

Report to Senate Finance Committee & House Health & Government Operations Committee on legality, obstacles, & benefits of upper payment limits on purchases & payor reimbursements of prescription drugs due Dec. 1, 2026 (Chapter 39, Acts of 2023; Code Health-General Article, sec. 21-2C-16)

Report to Senate Finance Committee & House Health & Government Operations Committee on upper payment limits on purchases & payor reimbursements of prescription drugs due Dec. 1, 2023 (Chapters 510 & 511, Acts of 2019; Chapter 692, Acts of 2019).

Maryland Constitutional Offices & Agencies
Maryland Departments
Maryland Independent Agencies
Maryland Executive Commissions, Committees, Task Forces, & Advisory Boards
Maryland Universities & Colleges
Maryland Counties
Maryland Municipalities
Maryland at a Glance

Maryland Manual On-Line

© Copyright Maryland State Archives